GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Market Cap

Vectus Biosystems (ASX:VBS) Market Cap : A$6.92 Mil (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vectus Biosystems's share price for the quarter that ended in Dec. 2023 was A$0.3. Vectus Biosystems's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 53.21 Mil. Therefore, Vectus Biosystems's market cap for the quarter that ended in Dec. 2023 was A$15.96 Mil.

Vectus Biosystems's quarterly market cap declined from Dec. 2022 (A$38.83 Mil) to Jun. 2023 (A$23.40 Mil) and declined from Jun. 2023 (A$23.40 Mil) to Dec. 2023 (A$15.96 Mil).

Vectus Biosystems's annual market cap declined from Jun. 2021 (A$42.73 Mil) to Jun. 2022 (A$35.72 Mil) and declined from Jun. 2022 (A$35.72 Mil) to Jun. 2023 (A$23.40 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vectus Biosystems's Enterprise Value for Today is A$4.04 Mil.


Vectus Biosystems Market Cap Historical Data

The historical data trend for Vectus Biosystems's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Market Cap Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Market Cap
Get a 7-Day Free Trial 7.95 17.03 42.73 35.72 23.40

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.89 35.72 38.83 23.40 15.96

Competitive Comparison of Vectus Biosystems's Market Cap

For the Biotechnology subindustry, Vectus Biosystems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Market Cap distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Market Cap falls into.



Vectus Biosystems Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Vectus Biosystems's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=A$0.44*53.1895
=A$23.40

Vectus Biosystems's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=A$0.3*53.2094
=A$15.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems  (ASX:VBS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Vectus Biosystems Market Cap Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines